Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (1021-1030 of 1,212) with videos related to

Pageof 122
Sort By:
Circulation|November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE TrialFrederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
Heart (British Cardiac Society)|June 26, 2015
Characterising and predicting bleeding in high-risk patients with an acute coronary syndromeRazi Khan, Renato D Lopes, Megan L Neely, et al.
Nucleic Acids Research|October 15, 2015
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligandsChristopher Southan, Joanna L Sharman, Helen E Benson, et al.
Circulation|August 28, 2022
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial InfarctionSunil V Rao, Bodo Kirsch, Deepak L Bhatt, et al.
European Journal of Epidemiology|August 29, 2018
Occupational radiation exposure and risk of cataract incidence in a cohort of US radiologic technologistsMark P Little, Cari M Kitahara, Elizabeth K Cahoon, et al.
Clinical Kidney Journal|February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Archives of Otolaryngology--Head & Neck Surgery|August 17, 2005
Corticosteroid response and supporting cell antibody in autoimmune hearing lossHisham Zeitoun, Jennifer Gray Beckman, H Alexander Arts, et al.
Science Advances|October 18, 2024
Beyond low lignin: Identifying the primary barrier to plant biomass conversion by fermentative bacteriaRyan G Bing, Daniel B Sulis, Morgan J Carey, et al.
American Heart Journal|March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationaleRenato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
JAMA Cardiology|February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysisRenato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
Pageof 122

Showing results (1021-1030 of 1,212) with videos related to

Sort By:
Pageof 122
Circulation|November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE TrialFrederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
Heart (British Cardiac Society)|June 26, 2015
Characterising and predicting bleeding in high-risk patients with an acute coronary syndromeRazi Khan, Renato D Lopes, Megan L Neely, et al.
Nucleic Acids Research|October 15, 2015
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligandsChristopher Southan, Joanna L Sharman, Helen E Benson, et al.
Circulation|August 28, 2022
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial InfarctionSunil V Rao, Bodo Kirsch, Deepak L Bhatt, et al.
European Journal of Epidemiology|August 29, 2018
Occupational radiation exposure and risk of cataract incidence in a cohort of US radiologic technologistsMark P Little, Cari M Kitahara, Elizabeth K Cahoon, et al.
Clinical Kidney Journal|February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Archives of Otolaryngology--Head & Neck Surgery|August 17, 2005
Corticosteroid response and supporting cell antibody in autoimmune hearing lossHisham Zeitoun, Jennifer Gray Beckman, H Alexander Arts, et al.
Science Advances|October 18, 2024
Beyond low lignin: Identifying the primary barrier to plant biomass conversion by fermentative bacteriaRyan G Bing, Daniel B Sulis, Morgan J Carey, et al.
American Heart Journal|March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationaleRenato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
JAMA Cardiology|February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysisRenato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
Pageof 122